We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong Exhibits Brand-New All-in-One Molecular Diagnosis System at analytica Vietnam 2023

By LabMedica International staff writers
Posted on 19 Apr 2023
Print article
Image: The new Panall 8000 all-in-one molecular diagnosis system is being showcased at analytica Vietnam 2023 (Photo courtesy of Tianlong)
Image: The new Panall 8000 all-in-one molecular diagnosis system is being showcased at analytica Vietnam 2023 (Photo courtesy of Tianlong)

Tianlong Science and Technology (Shaanxi, China), an innovative high-tech company specializing in molecular diagnostic products, is attending analytica Vietnam 2023, marking the first time Tianlong is exhibiting in Vietnam.

The 7th analytica Vietnam 2023 is taking place from April 19-21, 2023, at the Saigon Exhibition and Convention Center in Ho Chi Minh City, Vietnam. Recognized as the most crucial hub in the ASEAN Region, analytica Vietnam is celebrating its largest event to date, expecting 5,000 diagnostic professionals, top industry buyers, and investment decision-makers from over 30 countries worldwide.

At analytica Vietnam 2023, Tianlong is showcasing its brand-new all-in-one molecular diagnosis system Panall 8000, alongside its latest offerings in PCR laboratory diagnostics. Earlier, Tianlong had launched the Panall 8000 All-in-one Molecular Diagnosis System at Medlab Middle East 2023 where the new product had attracted significant attention.

The innovative lab booster, Tianlong Panall 8000, is a user-friendly and secure molecular diagnosis system that combines the functions of sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection, and result analysis. This system enables a truly seamless sample in-result out detection process and offers immense convenience for professionals through a one-key operation.

Alongside the Panall 8000, Tianlong is also presenting its innovative PCR lab solutions, including nucleic acid extractors, real-time PCR systems, sample processing systems, liquid handling systems, and compatible reagents, at analytica Vietnam 2023.

Related Links:
Tianlong Science and Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.